“A Review of the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): 453–457. Accessed February 1, 2026. https://skin.dermsquared.com/skin/article/view/1762.